References

• Majzoub JA, Muglia LJ. Knockout mice. N Engl J Med 1996; 334(14): 904–7.
   PubMed Web of Science ®Google Scholar
• Hannon GJ. RNA interference. Nature 2002; 418(6894): 244–51.
   PubMed Web of Science ®Google Scholar
• Hammond SM. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett 2005; 579(26): 5822–9.
   PubMed Web of Science ®Google Scholar
• Mello CC, Conte D, Jr. Revealing the world of RNA interference. Nature 2004; 431(7006): 338–42.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391(6669): 806–11.
   PubMed Web of Science ®Google Scholar
• Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA- directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404(6775): 293–6.
   PubMed Web of Science ®Google Scholar
• Guo J, Fisher KA, Darcy R, Cryan JF, O'Driscoll C. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery. Mol Biosyst 2010; 6(7): 1143–61.
   PubMed Web of Science ®Google Scholar
• Thakker DR, Natt F, Husken D, Maier R, Muller M, van der Putten H, et al. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A 2004; 101(49): 17270–5.
   PubMed Web of Science ®Google Scholar
• Thakker DR, Natt F, Husken D, van der Putten H, Maier R, Hoyer D, et al. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry 2005; 10(8): 782–9.
   Web of Science ®Google Scholar
• Salahpour A, Medvedev IO, Beaulieu JM, Gainetdinov RR, Caron MG. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 2007; 61(1): 65–9.
   PubMed Web of Science ®Google Scholar
• Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav 1984; 20(6): 917–23.
   Web of Science ®Google Scholar
• Flagel SB, Robinson TE. Quantifying the psychomotor activating effects of cocaine in the rat. Behav Pharmacol 2007; 18(4): 297–302.
   Web of Science ®Google Scholar
• Bahi A, Boyer F, Kolira M, Dreyer JL. In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour. J Neurochem 2005; 92(5): 1243–55.
   Web of Science ®Google Scholar
• Bahi A, Boyer F, Chandrasekar V, Dreyer JL. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology (Berl) 2008; 199(2): 169–82.
   Google Scholar
• Bahi A, Kusnecov A, Dreyer JL. The role of tissue-type plasminogen activator system in amphetamine-induced conditional place preference extinction and reinstatement. Neuropsychopharmacology 2008; 33(11): 2726–34.
   Web of Science ®Google Scholar
• Novak M, Halbout B, O'Connor EC, Rodriguez Parkitna J, Su T, Chai M, et al. Incentive learning underlying cocaine-seeking requires mGluR5 receptors located on dopamine D1 receptor-expressing neurons. J Neurosci 2010; 30(36): 11973–82.
   Web of Science ®Google Scholar
• Lasek AW, Janak PH, He L, Whistler JL, Heberlein U. Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav 2007; 6(8): 728–35.
   Web of Science ®Google Scholar
• Cortinez G, Sapag A, Israel Y. RNA interference against aldehyde dehydrogenase-2: development of tools for alcohol research. Alcohol 2009; 43(2): 97–104.
   Web of Science ®Google Scholar
• Bunney JN, Potkin SG. Circadian abnormalities, molecular clock genes and chronobiological treatments in depression. Br Med Bull 2008; 86:23–32.
   PubMed Web of Science ®Google Scholar
• Fox C, Merali Z, Harrison C. Therapeutic and protective effect of environmental enrichment against psychogenic and neurogenic stress. Behav Brain Res 2006; 175(1): 1–8.
   Web of Science ®Google Scholar
• Goetze U, Tolle R. Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy. Neuropsychobiology 1987; 18(4): 175–84.
   Web of Science ®Google Scholar
• Graham YP, Heim C, Goodman SH, Miller AH, Nemeroff CB. The effects of neonatal stress on brain development: implications for psychopathology. Dev Psychopathol 1999; 11(3): 545–65.
   PubMed Web of Science ®Google Scholar
• McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007; 114(2): 222–32.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Early life influences on life-long patterns of behavior and health. Ment Retard Dev Disabil Res Rev 2003; 9(3): 149–54.
   PubMedGoogle Scholar
• Post RM, Leverich GS, Xing G, Weiss RB. Developmental vulnerabilities to the onset and course of bipolar disorder. Dev Psychopathol 2001; 13(3): 581–98.
   PubMed Web of Science ®Google Scholar
• Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12 (Suppl. 1): S2–S19.
   PubMed Web of Science ®Google Scholar
• Sobczak S, Honig A, van Duinen MA, Riedel WJ. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord 2002; 4(6): 347–56.
   Web of Science ®Google Scholar
• Souetre E, Salvati E, Rix H, Pringuey D, Krebs B, Ardisson JL, et al. Effect of recovery on the cortisol circadian rhythm of depressed patients. Biol Psychiatry 1988; 24(3): 336–40.
   Web of Science ®Google Scholar
• Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, Kim DM. The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 2003; 27(1–2): 33–44.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006; 311(5757): 77–80.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Coque L, Cao JL, Kumar J, Chakravarty S, Asaithamby A, et al. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 2010; 68(6): 503–11.
   PubMed Web of Science ®Google Scholar
• Bahi A, Mineur YS, Picciotto MR. Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice. Biol Psychiatry 2009; 66(12): 1139–46.
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002; 53(4): 897–902.
   PubMed Web of Science ®Google Scholar
• Iacovides A, Siamouli M. Comorbid mental and somatic disorders: an epidemiological perspective. Curr Opin Psychiatry 2008; 21(4): 417–21.
   Web of Science ®Google Scholar
• Leucht S, Fountoulakis K. Improvement of the physical health of people with mental illness. Curr Opin Psychiatry 2006; 19(4): 411–2.
   Web of Science ®Google Scholar
• Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005; 438(7068): 662–6.
   PubMed Web of Science ®Google Scholar
• Joffe H, Cohen LS. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry 1998; 44(9): 798–811.
   PubMed Web of Science ®Google Scholar
• Steiner MS, Raghow S. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World J Urol 2003; 21(1): 31–6.
   Web of Science ®Google Scholar
• Spiteri T, Musatov S, Ogawa S, Ribeiro A, Pfaff DW, Agmo A. The role of the estrogen receptor alpha in the medial amygdala and ventromedial nucleus of the hypothalamus in social recognition, anxiety and aggression. Behav Brain Res 2010; 210(2): 211–20.
   Web of Science ®Google Scholar
• Shishkina GT, Kalinina TS, Dygalo NN. Attenuation of alpha2A-adrenergic receptor expression in neonatal rat brain by RNA interference or antisense oligonucleotide reduced anxiety in adulthood. Neuroscience 2004; 129(3): 521–8.
   Web of Science ®Google Scholar
• Sztainberg Y, Kuperman Y, Tsoory M, Lebow M, Chen A. The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1. Mol Psychiatry 2010; 15(9): 905–17.
   PubMed Web of Science ®Google Scholar
• Lesscher HM, McMahon T, Lasek AW, Chou WH, Connolly J, Kharazia V, et al. Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior. Genes Brain Behav 2008; 7(3): 323–33.
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59(12): 1116–27.
   PubMed Web of Science ®Google Scholar
• Eren-Kocak E, Turner CA, Watson SJ, Akil H. Short-hairpin RNA silencing of endogenous fibroblast growth factor 2 in rat hippocampus increases anxiety behavior. Biol Psychiatry 2011; 69(6): 534–40.
   Web of Science ®Google Scholar
• Green TA, Alibhai IN, Roybal CN, Winstanley CA, Theobald DE, Birnbaum SG, et al. Environmental enrichment produces a behavioral phenotype mediated by low cyclic adenosine monophosphate response element binding (CREB) activity in the nucleus accumbens. Biol Psychiatry 2010; 67(1): 28–35.
   Web of Science ®Google Scholar
• Kim KS, Lee KW, Baek IS, Lim CM, Krishnan V, Lee JK, et al. Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J Neurochem 2008; 107(1): 105–15.
   Web of Science ®Google Scholar
• Suetsugi M, Mizuki Y, Ushijima I, Kobayashi T, Tsuchiya K, Aoki T, et al. Appearance of frontal midline theta activity in patients with generalized anxiety disorder. Neuropsychobiology 2000; 41(2): 108–12.
   Web of Science ®Google Scholar
• Shin J, Gireesh G, Kim SW, Kim DS, Lee S, Kim YS, et al. Phospholipase C beta 4 in the medial septum controls cholinergic theta oscillations and anxiety behaviors. J Neurosci 2009; 29(49): 15375–85.
   PubMed Web of Science ®Google Scholar
• DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, et al. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A 2010; 107(19): 8800–5.
   PubMed Web of Science ®Google Scholar
• Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, et al. First-in-human mutation- targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 2010; 18(2): 442–6.
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010; 464(7291): 1067–70.
   PubMed Web of Science ®Google Scholar